IP Library Granted Patent US 12,571,036
Granted Patent B2
US 12,571,036 · App. 17/475,256 · Granted Mar 10, 2026

Methods, devices, and systems for analyte detection and analysis

Inventors: Gilad Almogy (Palo Alto, CA); Nathan Beckett (Oakland, CA); Jacob A. Wolf (Oakland, CA); Nathan Caswell (Sunnyvale, CA); Joseph Anthony (Oakland, CA); Jose Martin Sosa (San Jose, CA); Phillip Lee (South San Francisco, CA); Stephanie Kubecka (San Jose, CA)
Assignee: Ultima Genomics, Inc.
C12Q1/6874B01J19/0046B01L3/502715C12Q1/6809C12Q1/6825B01J2219/00536B01J2219/00596B01J2219/00689B01J2219/00702B01J2219/00722B01L2200/0647B01L2300/0654B01L2400/0409
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,571,036
App. No.
17/475,256
Granted
Mar 10, 2026
Kind
B2
Abstract

Provided are systems and methods for analyte detection and analysis. A system can comprise an open substrate. The open substrate may be configured to rotate or otherwise move. The open substrate can comprise an array of individually addressable locations, with analytes immobilized thereto. The substrate may be spatially indexed to identify nucleic acid molecules from one or more sources, and/or sequences thereof, with the respective one or more sources. A solution comprising a plurality of probes may be directed across the array to couple at least one of the plurality of probes with at least one of the analytes to form a bound probe. A detector can be configured to detect a signal from the bound probe via scanning of the substrate while minimizing temperature fluctuations of the substrate or optical aberrations caused by bubbles.

Claims (35)

1 . A system for nucleic acid sample processing, comprising:

a substrate comprising a first region and a second region different from said first region, wherein said first region or said second region comprises at least 10,000 indexed locations;

a first source comprising a first set of nucleic acid molecules, wherein said first region of said substrate comprises a first set of indexed locations comprising nucleic acid molecules of said first set of nucleic acid molecules;

a second source comprising a second set of nucleic acid molecules, wherein said second source is different than said first source, wherein said second region of said substrate comprises a second set of indexed locations comprising nucleic acid molecules of said second set of nucleic acid molecules;

a detector configured to detect signals from said first set of indexed locations that are indicative of at least one nucleotide having been incorporated into a growing nucleic acid strand that is complementary to a nucleic acid molecule of said first set of nucleic acid molecules; and

one or more processors, individually or in combination, configured to (i) receive said signals from said detector and (ii) associate each nucleic acid molecule of said first set of indexed locations with said first source or (iii) associate each nucleic acid molecule of said second set of indexed locations with said second source.

2 . The system of claim 1 , wherein said one or more processors are operatively coupled to said first source and said second source.

3 . The system of claim 2 , wherein said one or more processors are individually or collectively programmed to direct a fluid flow unit to dispense a solution from said first source or said second source to said substrate.

4 . The system of claim 1 , wherein said detector comprises an optical imaging unit that is operatively coupled to said one or more processors.

5 . The system of claim 4 , wherein said optical imaging unit is configured to detect (i) signals from said first region to determine a first set of sequences of said nucleic acid molecules of said first set of indexed locations and (ii) signals from said second region to determine a second set of sequences of said nucleic acid molecules of said second set of indexed locations.

6 . The system of claim 5 , wherein said one or more processors are configured, individually or in combination, (1) to associate said first set of sequences to said first source using said first set of indexed locations and (2) to associate said second set of sequences to said second source using said second set of indexed locations.

7 . The system of claim 6 , wherein said first set of sequences is associated with said first source and said second set of sequences is associated with said second source in absence of determining a barcode sequence of said first set of nucleic acid molecules and said second set of nucleic acid molecules.

8 . The system of claim 1 , wherein each nucleic acid molecule of said first set of nucleic acid molecules and said second set of nucleic acid molecules comprises a synthetic sequence of no more than 6 bases in length, and wherein a subset of nucleic acid molecules originating from a same source each comprises a common synthetic sequence, which common synthetic sequence is different from synthetic sequences of another subset of nucleic acid molecules originating from a different source.

9 . The system of claim 1 , wherein said substrate comprises a plurality of binders, wherein a binder of said plurality of binders is capable of immobilizing both said nucleic acid molecules of said first set of nucleic acid molecules and said nucleic acid molecules of said second set of nucleic acid molecules, wherein said nucleic acid molecules of said first set of nucleic acid molecules are immobilized to said first set of indexed locations via a first set of binders of said plurality of binders, and wherein said nucleic acid molecules of said second set of nucleic acid molecules are immobilized to said second set of indexed locations via a second set of binders of said plurality of binders different from said first set of binders.

10 . The system of claim 9 , wherein said binder is configured to immobilize said first set of nucleic acid molecules or said second set of nucleic acid molecules using one or more interactions selected from a group consisting of: hydrophilic interactions, hydrophobic interactions, electrostatic interactions, and hybridization interactions.

11 . The system of claim 1 , wherein said first region and said second region are adjacent and in contact on said substrate.

12 . The system of claim 1 , wherein said substrate comprises (1) a plurality of first regions, including said first region, configured to receive nucleic acid molecules of said first source and (2) a plurality of second regions, including said second region, configured to receive nucleic acid molecules of said second source, which plurality of first regions and plurality of second regions are arranged on said substrate such that a given first region of said plurality of first regions is not in contact with another first region of said plurality of first regions.

13 . The system of claim 12 , wherein said plurality of first regions and said plurality of second regions are arranged as alternating regions on said substrate.

14 . The system of claim 12 , wherein said plurality of first regions and said plurality of second regions are arranged as radially alternating regions on said substrate.

15 . The system of claim 12 , wherein (i) said plurality of first regions are chemically distinct from said plurality of second regions, or (ii) said plurality of first regions and said plurality of second regions are separated by barriers.

16 . The system of claim 1 , wherein said first region and said second region are of different sizes or comprise different numbers of individually addressable locations on said substrate.

17 . The system of claim 1 , further comprising, a first loading fluid comprising said first set of nucleic acid molecules and a second loading fluid comprising said second set of nucleic acid molecules, wherein said first loading fluid and said second loading fluid are immiscible.

18 . The system of claim 1 , further comprising a magnetic source configured to direct said first set of nucleic acid molecules or said second set of nucleic acid molecules to said substrate.

19 . The system of claim 1 , wherein said first region and said second region are separated by a barrier on said substrate, and wherein said barrier comprises a viscous solution, polyethylene glycol (PEG), a fluid that is immiscible with a loading solution comprising said first set of nucleic acid molecules and said second set of nucleic acid molecules, an air knife, an injection molded guide, or a hydrophobic region.

20 . The system of claim 1 , wherein said substrate is substantially planar.

21 . The system of claim 1 , wherein said substrate is patterned.

22 . The system of claim 1 , wherein said substrate is rotatable about a rotational axis.

23 . The system of claim 22 , wherein said first set of indexed locations and said second set of indexed locations have different radial distances from said rotational axis.

24 . The system of claim 1 , wherein said nucleic acid molecules of said first set of nucleic acid molecules have sequences that are different from sequences of said nucleic acid molecules of said second set of nucleic acid molecules.

25 . The system of claim 1 , wherein said nucleic acid molecules of said first set of nucleic acid molecules have the same sequences as said nucleic acid molecules of said second set of nucleic acid molecules.

26 . The system of claim 1 , wherein said first set of nucleic acid molecules is attached to a plurality of beads, which plurality of beads is immobilized adjacent to said substrate at said first set of indexed locations.

27 . The system of claim 26 , wherein a bead of said plurality of beads comprises a plurality of nucleic acid molecules attached thereto, and wherein said plurality of nucleic acid molecules comprises amplification products derived from a template nucleic acid molecule.

28 . The system of claim 27 , wherein said first set of indexed locations comprises at least 100 individually addressable locations, and wherein said second set of indexed locations comprises at least 100 individually addressable locations.

29 . The system of claim 28 , wherein said first set of indexed locations and said second set of indexed locations comprise at least about 5,000,000,000 individually addressable locations.

30 . The system of claim 28 , wherein said first set of nucleic acid molecules is attached to a first plurality of beads and said second set of nucleic acid molecules is attached to a second plurality of beads, and wherein said first plurality of beads and said second plurality of beads are associated to said at least 100 individually addressable locations of said first set of indexed locations or said at least 100 individually addressable locations of said second set of indexed locations.

Assignments (2)
SECURITY INTEREST Recorded Apr 3, 2026
From: ULTIMA GENOMICS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 075435/0595 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2023
From: ALMOGY, GILAD; BECKETT, NATHAN; WOLF, JACOB A.; CASWELL, NATHAN; ANTHONY, JOSEPH; SOSA, JOSE MARTIN; LEE, PHILLIP; KUBECKA, STEPHANIE
To: ULTIMA GENOMICS, INC.
Reel/Frame 064913/0105 →
Continuity (5)
Continuation 17155226 · Jan 22, 2021
Continuation 16445798 · Jun 19, 2019
Provisional Application 62837684 · Apr 23, 2019
Provisional Application 62818549 · Mar 14, 2019
Related Publication 20220064727A1 · Mar 3, 2022
References Cited (236)
US 3707723A · Levene · 1972 [cited by applicant]
US 4611881A · Schmidt et al. · 1986 [cited by applicant]
US 5216247A · Wang et al. · 1993 [cited by applicant]
US 5307146A · Porter et al. · 1994 [cited by applicant]
US 5409811A · Tabor et al. · 1995 [cited by applicant]
US 5607863A · Chandler · 1997 [cited by applicant]
US 5641006A · Autrey et al. · 1997 [cited by applicant]
US 5641658A · Adams et al. · 1997 [cited by applicant]
US 5674716A · Tabor et al. · 1997 [cited by applicant]
US 5800997A · Beck · 1998 [cited by applicant]
US 6139831A · Shivashankar et al. · 2000 [cited by applicant]
US 6320609B1 · Buchanan et al. · 2001 [cited by applicant]
US 6466352B1 · Shahar et al. · 2002 [cited by applicant]
US 6737238B2 · Suzuki et al. · 2004 [cited by applicant]
US 7623289B2 · Harada · 2009 [cited by applicant]
US 7689022B2 · Weiner et al. · 2010 [cited by applicant]
US 7906285B2 · Drmanac · 2011 [cited by applicant]
US 7939264B1 · Densham · 2011 [cited by applicant]
US 8431903B2 · Duhr et al. · 2013 [cited by applicant]
US 8475739B2 · Holmes et al. · 2013 [cited by applicant]
US 8574847B2 · Becker et al. · 2013 [cited by applicant]
US 8597882B2 · Corbett et al. · 2013 [cited by applicant]
US 8772473B2 · Huang et al. · 2014 [cited by applicant]
US 9795961B1 · Koh et al. · 2017 [cited by applicant]
US 9891177B2 · Vazhaeparambil et al. · 2018 [cited by applicant]
US 10267790B1 · Barbee et al. · 2019 [cited by applicant]
US 10273528B1 · Barbee et al. · 2019 [cited by applicant]
US 10344328B2 · Barbee et al. · 2019 [cited by applicant]
US 10512911B1 · Beckett et al. · 2019 [cited by applicant]
US 10830703B1 · Almogy et al. · 2020 [cited by applicant]
US 10852518B1 · Almogy et al. · 2020 [cited by applicant]
US 10900078B2 · Almogy et al. · 2021 [cited by applicant]
US 11118223B2 · Almogy et al. · 2021 [cited by applicant]
US 11155868B2 · Almogy et al. · 2021 [cited by applicant]
US 11268143B2 · Beckett et al. · 2022 [cited by applicant]
US 11396015B2 · Beckett et al. · 2022 [cited by applicant]
US 11499962B2 · Barbee et al. · 2022 [cited by applicant]
US 11512350B2 · Almogy et al. · 2022 [cited by applicant]
US 11591651B2 · Almogy et al. · 2023 [cited by applicant]
US 11648554B2 · Beckett et al. · 2023 [cited by applicant]
US 11732298B2 · Almogy et al. · 2023 [cited by applicant]
US 11747323B2 · Barbee et al. · 2023 [cited by applicant]
US 12031180B2 · Beckett et al. · 2024 [cited by applicant]
US 12188924B2 · Barbee et al. · 2025 [cited by applicant]
US 12239980B2 · Beckett et al. · 2025 [cited by applicant]
US 20020006622A1 · Bradley et al. · 2002 [cited by applicant]
US 20020009015A1 · Laugharn et al. · 2002 [cited by applicant]
US 20020022261A1 · Anderson et al. · 2002 [cited by applicant]
US 20020055112A1 · Patil et al. · 2002 [cited by applicant]
US 20020064780A1 · Gold et al. · 2002 [cited by applicant]
US 20020072243A1 · Craighead et al. · 2002 [cited by applicant]
US 20020074517A1 · Krutchinsky et al. · 2002 [cited by applicant]
US 20020168652A1 · Werner et al. · 2002 [cited by applicant]
US 20020172980A1 · Phan et al. · 2002 [cited by applicant]
US 20020177144A1 · Remacle et al. · 2002 [cited by applicant]
US 20030054376A1 · Mullis et al. · 2003 [cited by applicant]
US 20030193589A1 · Lareau et al. · 2003 [cited by applicant]
US 20040071888A1 · Chondroudis et al. · 2004 [cited by applicant]
US 20050037484A1 · Staimer et al. · 2005 [cited by applicant]
US 20050186580A1 · Dellinger et al. · 2005 [cited by applicant]
US 20050237480A1 · Allbritton et al. · 2005 [cited by applicant]
US 20060078934A1 · Desmet et al. · 2006 [cited by applicant]
US 20060078935A1 · Werner et al. · 2006 [cited by applicant]
US 20060263791A1 · Moon et al. · 2006 [cited by applicant]
US 20070099289A1 · Irimia et al. · 2007 [cited by applicant]
US 20070275193A1 · DeSimone et al. · 2007 [cited by applicant]
US 20070290702A1 · Lee · 2007 [cited by applicant]
US 20080038163A1 · Boege et al. · 2008 [cited by applicant]
US 20080242560A1 · Gunderson et al. · 2008 [cited by applicant]
US 20080254259A1 · Nishi et al. · 2008 [cited by applicant]
US 20090098541A1 · Southern et al. · 2009 [cited by applicant]
US 20090135385A1 · Gellrich et al. · 2009 [cited by applicant]
US 20090263002A1 · Cremer et al. · 2009 [cited by applicant]
US 20090263807A1 · Yotoriyama · 2009 [cited by applicant]
US 20090305431A1 · Hodges et al. · 2009 [cited by applicant]
US 20090308742A1 · Paranjape · 2009 [cited by applicant]
US 20100041562A1 · Li et al. · 2010 [cited by applicant]
US 20100101104A1 · Grzesiak et al. · 2010 [cited by applicant]
US 20100151564A1 · Beebe et al. · 2010 [cited by applicant]
US 20100167308A1 · Miller et al. · 2010 [cited by applicant]
US 20100210475A1 · Lee et al. · 2010 [cited by applicant]
US 20100330578A1 · Duhr et al. · 2010 [cited by applicant]
US 20110086361A1 · Klunder et al. · 2011 [cited by applicant]
US 20110178285A1 · Lebl et al. · 2011 [cited by applicant]
US 20110312622A1 · Azimi et al. · 2011 [cited by applicant]
US 20120068059A1 · Montes Usategui et al. · 2012 [cited by applicant]
US 20120126142A1 · Matsui et al. · 2012 [cited by applicant]
US 20120282708A1 · Corbett et al. · 2012 [cited by applicant]
US 20120316074A1 · Saxonov · 2012 [cited by applicant]
US 20130005585A1 · Anderson et al. · 2013 [cited by applicant]
US 20130038719A1 · Canini et al. · 2013 [cited by applicant]
US 20130076852A1 · Bai et al. · 2013 [cited by applicant]
US 20140152888A1 · Staker et al. · 2014 [cited by applicant]
US 20140162275A1 · Kotseroglou · 2014 [cited by applicant]
US 20140261577A1 · Furukawa et al. · 2014 [cited by applicant]
US 20140287423A1 · Nurse · 2014 [cited by applicant]
US 20150071898A1 · Liu et al. · 2015 [cited by applicant]
US 20150125346A1 · Schaff et al. · 2015 [cited by applicant]
US 20150212310A1 · Fukuda et al. · 2015 [cited by applicant]
US 20150270146A1 · Yoshihara et al. · 2015 [cited by applicant]
US 20160032380A1 · Craighead et al. · 2016 [cited by applicant]
US 20160041135A1 · Lannutti et al. · 2016 [cited by applicant]
US 20160061733A1 · Wu et al. · 2016 [cited by applicant]
US 20160076025A1 · Boutell et al. · 2016 [cited by applicant]
US 20160076978A1 · Dave et al. · 2016 [cited by applicant]
US 20160168626A1 · Danehy et al. · 2016 [cited by applicant]
US 20160184870A1 · Miura et al. · 2016 [cited by applicant]
US 20160246170A1 · Bowen et al. · 2016 [cited by applicant]
US 20160314575A1 · Matsuo et al. · 2016 [cited by applicant]
US 20160319334A1 · Barany et al. · 2016 [cited by applicant]
US 20170123198A1 · Singer et al. · 2017 [cited by applicant]
US 20170136434A1 · Barnard et al. · 2017 [cited by applicant]
US 20180207920A1 · Venkatesan et al. · 2018 [cited by applicant]
US 20190271038A1 · Almogy et al. · 2019 [cited by applicant]
US 20190271039A1 · Almogy et al. · 2019 [cited by applicant]
US 20190291115A1 · Kaplan et al. · 2019 [cited by applicant]
US 20190331903A1 · Wald et al. · 2019 [cited by applicant]
US 20200164379A1 · Kaplan et al. · 2020 [cited by applicant]
US 20200179925A1 · Beckett et al. · 2020 [cited by applicant]
US 20200179926A1 · Beckett et al. · 2020 [cited by applicant]
US 20200326327A1 · Barbee et al. · 2020 [cited by applicant]
US 20210047688A1 · Almogy et al. · 2021 [cited by applicant]
US 20210054454A1 · Almogy et al. · 2021 [cited by applicant]
US 20210199647A1 · Beckett et al. · 2021 [cited by applicant]
US 20210277464A1 · Beckett et al. · 2021 [cited by applicant]
US 20210354126A1 · Beckett et al. · 2021 [cited by applicant]
US 20240027425A1 · Barbee et al. · 2024 [cited by applicant]
US 20240360505A1 · Beckett et al. · 2024 [cited by applicant]
US 20250012778A1 · Barbee et al. · 2025 [cited by applicant]
US 20250262618A1 · Beckett et al. · 2025 [cited by applicant]
CN 1142868A · 1997 [cited by applicant]
CN 103547255A · 2014 [cited by applicant]
CN 105759027A · 2016 [cited by applicant]
CN 107735664A · 2018 [cited by applicant]
EP 0865606A1 · 1998 [cited by applicant]
JP 2000304688A · 2000 [cited by applicant]
JP 2003511043A · 2003 [cited by applicant]
JP 2005345597A · 2005 [cited by applicant]
JP 2008262983A · 2008 [cited by applicant]
JP 2010117712A · 2010 [cited by applicant]
JP 2010536009A · 2010 [cited by applicant]
JP 2012522225A · 2012 [cited by applicant]
JP 2015529858A · 2015 [cited by applicant]
JP 2018511338A · 2018 [cited by applicant]
JP 2018516591A · 2018 [cited by applicant]
JP 2018143154A · 2018 [cited by applicant]
WO WO0037680A1 · 2000 [cited by applicant]
WO WO0039625A2 · 2000 [cited by applicant]
WO WO0039625A3 · 2000 [cited by applicant]
WO WO03102535A2 · 2003 [cited by applicant]
WO WO03102535A3 · 2004 [cited by applicant]
WO WO2008016335A1 · 2008 [cited by applicant]
WO WO2014127379A1 · 2014 [cited by applicant]
WO WO2014143981A1 · 2014 [cited by applicant]
WO WO2014143981A9 · 2014 [cited by applicant]
WO WO2015119254A1 · 2015 [cited by applicant]
WO WO2014143981A8 · 2015 [cited by applicant]
WO WO2016161163A2 · 2016 [cited by applicant]
WO WO2016168687A1 · 2016 [cited by applicant]
WO WO2018064297A1 · 2018 [cited by applicant]
WO WO2018144582A1 · 2018 [cited by applicant]
WO WO2019099886A1 · 2019 [cited by applicant]
WO WO2020034143A1 · 2020 [cited by applicant]
WO WO2020118172A1 · 2020 [cited by applicant]
WO WO2020186243A1 · 2020 [cited by applicant]
WO WO2022072652A1 · 2022 [cited by applicant]
Co-pending U.S. Appl. No. 17/962,163, inventors Barbee; Kristopher et al., filed Oct. 7, 2022. [cited by applicant]
EP19894196.5 European Search Report dated Aug. 12, 2022. [cited by applicant]
He, R-Y., et al. Study of cell adhesion and migration by using a plasmon-enhanced total internal reflection fluorescence microscope. Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues IV. vol. 6088.… [cited by applicant]
U.S. Appl. No. 16/416,856 Final Office Action dated Oct. 5, 2022. [cited by applicant]
U.S. Appl. No. 16/862,196 Notice of Allowance dated Jul. 7, 2022. [cited by applicant]
Britannica, The Editors of Encyclopedia. “fluid”. Encyclopedia Britannica, May 11, 2021, https://www.britannica.com/science/fluid-physics. Accessed on Jan. 21, 2022. [cited by applicant]
PCT/US2019/064916 International Search Report and Written Opinion dated Apr. 7, 2020. [cited by applicant]
PCT/US2021/052902 International Search Report and Written Opinion dated Feb. 17, 2022. [cited by applicant]
U.S. Appl. No. 16/665,540 Non-Final Office Action dated Jan. 10, 2022. [cited by applicant]
U.S. Appl. No. 16/665,559 Non-Final Office Action dated Feb. 7, 2022. [cited by applicant]
Explanation of “Probe” in the Dictionary of Nutrition and Biochemistry. Retrieved from website on Jun. 30, 2023: https://kotobank.jp/word/%E3%83%97%E3%83%AD%E3%83%BC%E3%83%96-675975. [cited by applicant]
Spencer, Harold, and F.R.S. Jones. Variations of the Earth's Rotation. Physics and Chemistry of the Earth, vol. 4 (1961): 186-210. [cited by applicant]
U.S. Appl. No. 17/336,377 Office Action dated Sep. 28, 2023. [cited by applicant]
U.S. Appl. No. 17/543,521 Office Action dated Oct. 12, 2023. [cited by applicant]
U.S. Appl. No. 16/416,889 Office Action dated Mar. 26, 2024. [cited by applicant]
U.S. Appl. No. 17/543,521 Notice of Allowance dated Jun. 5, 2024. [cited by applicant]
U.S. Appl. No. 17/962,163 Office Action dated Mar. 3, 2023. [cited by applicant]
U.S. Appl. No. 18/224,378 Notice of Allowance dated Apr. 29, 2024. [cited by applicant]
EP20770906.4 Extended European Search Report dated Feb. 20, 2023. [cited by applicant]
Adessi et al. Solid phase DNA amplification: Charcterisation of primer attachment and amplification mechanisms, Nucl. Acids Res, 2000, 28(20):E87. [cited by applicant]
Bioptechs. Product information for the Bioptechs Objective Heather. Available at http://bioptechs.com/product/objective-heater/. Accessed on Jun. 25, 2019. [cited by applicant]
Brenner, et al. Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays. Nat Biotechnol. Jun. 2000;18(6):630-4. [cited by applicant]
Brenner et al. In vitro cloning of complex mixtures of DNA on microbeads: Physical separation of differentially expressed cDNAs, Proc. Natl. Acad. Sci. USA 2000, 97(4):1665-1670. [cited by applicant]
Co-pending U.S. Application No. 202117543521, inventors Beckett; Nathan et al., filed on Dec. 6, 2021. [cited by applicant]
Co-pending U.S. Application No. 202017001174, inventors Almogy; Gilad et al., filed on Aug. 24, 2020. [cited by applicant]
Co-pending U.S. Application No. 202017003400, inventors Almogy; Gilad et al., filed on Aug. 26, 2020. [cited by applicant]
Dressman, et al. Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations. Proc Natl Acad Sci USA. 2003; 100(15):8817-8822. [cited by applicant]
EP20180878612 European Search Report dated Jul. 14, 2021. [cited by applicant]
Lizardi, et al. Mutation detection and single-molecule counting using isothermal rolling-circle amplification. Nat Genet. Jul. 1998;19(3):225-32. [cited by applicant]
MIT Technology Review. China's BGI says it can sequence a genome for just $100. Available at https://www.technologyreview.com/2020/02/26/905658/china-bgi-100-dollar-genome. Accessed on Feb. 19, 2021. [cited by applicant]
Mitra, et al. Digital genotyping and haplotyping with polymerase colonies. Proceedings of the National Academy of Sciences of the United States of America vol. 100,10 (2003): 5926-31. [cited by applicant]
Mitra, et al. Fluorescent in situ sequencing on polymerase colonies, Anal. Biochem, 320:55-65. (2003). [cited by applicant]
PCT/US020/022816 International Search Report and Written Opinion dated Jul. 30, 2020. [cited by applicant]
PCT/US18/61598 International Search Report and Written Opinion dated Mar. 15, 2019. [cited by applicant]
Pemov, A. et al. DNA analysis with multiplex microarray-enhanced PCR. Nucleic acids research vol. 33:2 (2005). [cited by applicant]
Qin, et al. High-throughput, low-cost and rapid DNA sequencing using surface-coating techniques. bioRxiv (2020). [cited by applicant]
Reinartz, et al. Massively parallel signature sequencing (MPSS) as a tool for in-depth quantitative gene expression profiling in all organisms. Brief Funct Genomic Proteomic. Feb. 2002;1(1):95-104. [cited by applicant]
Spatial Transcriptomics. Workflow. Available at https://spatialtranscriptomics.com/workflow/. Accessed on Jun. 25, 2019. [cited by applicant]
Tabor, et al., Effect of manganese ions on the incorporation of dideoxynucleotides by bacteriophage T7 DNA polymerase and [cited by applicant]
U.S. Appl. No. 15/974,364 Office Action dated Aug. 7, 2018. [cited by applicant]
U.S. Appl. No. 15/974,543 Notice of Allowance dated Dec. 13, 2018. [cited by applicant]
U.S. Appl. No. 15/974,543 Office Action dated Aug. 7, 2018. [cited by applicant]
U.S. Appl. No. 16/445,798 Notice of Allowance dated Dec. 18, 2020. [cited by applicant]
U.S. Appl. No. 16/445,798 Notice of Allowance dated Dec. 4, 2020. [cited by applicant]
U.S. Appl. No. 16/445,798 Notice of Allowance dated Sep. 18, 2020. [cited by applicant]
U.S. Appl. No. 16/445,798 Office Action dated May 8, 2020. [cited by applicant]
U.S. Appl. No. 16/677,067 Notice of Allowance dated Aug. 12, 2020. [cited by applicant]
U.S. Appl. No. 16/677,067 Notice of Allowance dated Jul. 1, 2020. [cited by applicant]
U.S. Appl. No. 16/677,067 Notice of Allowance dated Jun. 19, 2020. [cited by applicant]
U.S. Appl. No. 16/677,067 Notice of Allowance dated Sep. 21, 2020. [cited by applicant]
U.S. Appl. No. 16/677,115 Notice of Allowance dated Aug. 21, 2020. [cited by applicant]
U.S. Appl. No. 16/677,115 Notice of Allowance dated Jul. 14, 2020. [cited by applicant]
U.S. Appl. No. 16/953,071 Notice of Allowance dated May 26, 2021. [cited by applicant]
U.S. Appl. No. 16/953,071 Notice of Allowance dated May 5, 2021. [cited by applicant]
U.S. Appl. No. 16/953,071 Office Action dated Apr. 22, 2021. [cited by applicant]
U.S. Appl. No. 16/953,071 Office Action dated Jan. 15, 2021. [cited by applicant]
U.S. Appl. No. 17/155,226 Notice of Allowance dated Aug. 27, 2021. [cited by applicant]
U.S. Appl. No. 17/155,226 Notice of Allowance dated Jul. 6, 2021. [cited by applicant]
U.S. Appl. No. 17/155,226 Office Action dated Mar. 18, 2021. [cited by applicant]
U.S. Appl. No. 17/308,241 Notice of Allowance dated Nov. 16, 2021. [cited by applicant]
U.S. Appl. No. 17/308,241 Office Action dated Jul. 26, 2021. [cited by applicant]
U.S. Appl. No. 15/974,364 Notice of Allowance dated Feb. 28, 2019. [cited by applicant]
U.S. Appl. No. 15/974,441 Notice of Allowance dated Nov. 21, 2018. [cited by applicant]
U.S. Appl. No. 15/974,441 Office Action dated Aug. 3, 2018. [cited by applicant]
U.S. Appl. No. 16/445,798 Office Action dated Nov. 6, 2019. [cited by applicant]
U.S. Appl. No. 16/677,067 Office Action dated Feb. 28, 2020. [cited by applicant]
U.S. Appl. No. 16/677,115 Office Action dated Mar. 24, 2020. [cited by applicant]
U.S. Appl. No. 18/224,378 Notice of Allowance dated Oct. 30, 2024. [cited by applicant]
U.S. Appl. No. 18/776,046 Notice of Allowance dated Jul. 22, 2025. [cited by applicant]
U.S. Appl. No. 18/776,046 Office Action dated Jun. 18, 2025. [cited by applicant]